1. Home
  2. GCBC vs NGNE Comparison

GCBC vs NGNE Comparison

Compare GCBC & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greene County Bancorp Inc.

GCBC

Greene County Bancorp Inc.

HOLD

Current Price

$23.78

Market Cap

374.8M

Sector

Finance

ML Signal

HOLD

Logo Neurogene Inc.

NGNE

Neurogene Inc.

HOLD

Current Price

$17.38

Market Cap

327.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCBC
NGNE
Founded
1889
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
374.8M
327.8M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
GCBC
NGNE
Price
$23.78
$17.38
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$40.14
AVG Volume (30 Days)
11.7K
111.0K
Earning Date
01-21-2026
03-23-2026
Dividend Yield
1.65%
N/A
EPS Growth
39.39
N/A
EPS
2.15
N/A
Revenue
$81,989,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.08
N/A
Revenue Growth
24.51
N/A
52 Week Low
$20.00
$6.88
52 Week High
$27.62
$37.27

Technical Indicators

Market Signals
Indicator
GCBC
NGNE
Relative Strength Index (RSI) 49.28 45.98
Support Level $23.55 $16.20
Resistance Level $24.42 $17.95
Average True Range (ATR) 0.62 1.36
MACD 0.01 0.02
Stochastic Oscillator 37.74 34.81

Price Performance

Historical Comparison
GCBC
NGNE

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

About NGNE Neurogene Inc.

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Share on Social Networks: